TrialBlood advances2018

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance).

John C Byrd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.